Molecular Testing Improves Nodular Fasciitis Diagnosis

• by Andrea Surnit

• April 3, 2026

Consensus Guidance May Improve Sinonasal Mass Outcomes

Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.

• by Andrea Surnit

• June 2, 2026

• 4 min

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

• by Arthur Allen

• May 15, 2026

• 9 min

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

• by Kathryn Wighton

• July 2, 2026

• 3 min